Side-effects: latest news

Side-effects resources

  • Antiretroviral drugs chart

    A one-page reference guide to the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions....

    From: Antiretroviral drugs chart

    Information level Level 1
  • HIV treatment in women

    The evidence available suggests that HIV treatment works well for women. Unless you are pregnant, the recommendations for HIV treatment are the same for both women and...

    From: Booklets

    Information level Level 2
  • Side-effects

    Like all medications, anti-HIV drugs can cause side-effects and these can be a reason why people don’t take their treatment properly. The risk of side-effects can vary between...

    From: Booklets

    Information level Level 2
  • Side-effects

    Like all medication, anti-HIV drugs can have side-effects. Read more here on what these are and how to deal with them if you experience side-effects....

    From: Living with HIV

    Information level Level 2
  • Side-effects

    The booklet provides information about possible side-effects of HIV treatment. ...

    From: Booklets

    Information level Level 2
  • My drugs chart

    My drugs chart provides information on all the anti-HIV drugs currently licensed for use in Europe.Select your chosen drugs and drag them onto the area...

    From: My drugs chart

  • Side-effects

    We take medicines to make us better or to keep us well, but all medicines can cause unwanted secondary effects. These are usually called side-effects,...

    From: Factsheets

    Information level Level 2
  • Neuropathy - nerve pain

    Neuropathy is damage to the nerves. Nerves transmit signals within the brain and spinal cord (the central nervous system or CNS), and extend from the...

    From: Factsheets

    Information level Level 2
  • Facial wasting

    New cases of facial wasting caused by anti-HIV drugs are now rare in the UK.Fat loss from the face is one of the components of...

    From: Factsheets

    Information level Level 2
  • Hyperbilirubinaemia

    Bilirubin is a waste product produced by the liver during the breakdown of old red blood cells. The technical term for abnormally high levels of...

    From: Factsheets

    Information level Level 2
  • Lactic acidosis

    Lactic acidosis is a serious side-effect of the nucleoside reverse transcriptase inhibitor (NRTI) class of anti-HIV drugs. This class includes AZT (zidovudine, Retrovir), 3TC (lamivudine, Epivir), d4T...

    From: Factsheets

    Information level Level 2
  • Skin problems

    There are three main causes of skin problems in people with HIV: interactions between the immune system and HIV, infections, and side-effects of drugs. Some...

    From: Factsheets

    Information level Level 2
  • Pain

    Every day most of us will experience physical pain of some sort. For the most part it will cause only minor discomfort and won’t interfere...

    From: Factsheets

    Information level Level 2
  • Nausea and vomiting

    Nausea is a word for the feeling of wanting to vomit or be sick. Most people with HIV will experience nausea and vomiting at some...

    From: Factsheets

    Information level Level 2
  • Diarrhoea

    Diarrhoea is common among people with HIV. It can be a side-effect of anti-HIV drugs as well as some other medicines, such as antibiotics. Diarrhoea...

    From: Factsheets

    Information level Level 2
  • Tiredness and fatigue

    Tiredness and fatigue are common problems among people with HIV. There are many possible causes and treatments and there are also things you can do...

    From: Factsheets

    Information level Level 2
  • Changing treatment due to side-effects

    All drugs can cause side-effects and the drugs used in treating HIV are no exception. Changing treatment because of side-effects is quite common. ...

    From: Factsheets

    Information level Level 2
  • Side effects

    The most common side effects are the result of your body getting used to a new drug. After a few weeks, these side effects usually...

    From: The basics

    Information level Level 1
  • Lipodystrophy

    Lipodystrophy (lip-oh-diss-troh-fee) is the name for changes in body shape first reported in 1997 among people taking HIV treatment. It was originally thought that the...

    From: Factsheets

    Information level Level 2
  • Side-effects

    Information on the side-effects associated with anti-HIV treatments and other drugs, including advice on how to cope with them, and whether treatment should be stopped...

    From: HIV treatments directory

    Information level Level 4
  • Effect of genetic variation on side-effects of HIV drugs

    In addition to drug levels, the other major area of research interest in pharmacogenetics is the association of human genetic variation with the incidence or...

    From: HIV treatments directory

    Information level Level 4
  • Your shape

    This booklet covers the side effects of fat loss, fat gain, raised blood fats and raised blood sugars....

    From: 'Your' booklets series

    Information level Level 1
  • Your treatment

    This booklet gives a basic, but comprehensive introduction to HIV treatment....

    From: 'Your' booklets series

    Information level Level 1

Side-effects features

Side-effects in your own words

Side-effects news from aidsmap

More news

Side-effects news selected from other sources

  • IDWeek 2014: AbbVie 3D HCV Regimen Well-tolerated in PEARL Trials

    AbbVie's 3D hepatitis C regimen containing paritaprevir (ABT-450), ombitasvir, and dasabuvir was generally well-tolerated in the Phase 3 PEARL trials, according to a pooled analysis presented at IDWeek 2014 last week in Philadelphia. Serious side effects were uncommon and few people discontinued treatment for this reason.

    16 October 2014 | HIVandHepatitis.com
  • IDWeek 2014: Efavirenz Not Linked to Suicide in Analysis of Insurance Records

    The non-nucleoside reverse transcriptase inhibitor efavirenz (Sustiva, also in the Atripla single-tablet regimen) was not associated with a higher rate of suicidal thoughts or attempts in an analysis conducted by manufacturer Bristol-Myers Squibb (BMS), researchers reported at the 2014 IDWeek meeting last week in Philadelphia.

    16 October 2014 | HIVandHepatitis.com
  • Effective treatments available for HIV patients not eligible for efavirenz regimens

    HIV drug regimens that do not include efavirenz are effective as first-line antiretroviral therapy, a new American clinical trial found. The finding is important for patients who are not eligible for treatment with efavirenz, including women considering becoming pregnant and patients with a history of severe psychiatric disorders.

    07 October 2014 | Science Daily
  • Why I Refused, Then Later Embraced, HIV Treatment

    "On good days, adhering to my pill is a positive affirmation of my life, an exercise in self-love. On bad days, it's just a pill I need to swallow, not terribly bitter but as mildly annoying as having to shave or tie my shoelaces every day. It's yet another thing to add to my list of things, but I do it anyway." Josh Kruger on his ambiguous relationship to HIV treatment.

    01 October 2014 | TheBody.com
  • Guidelines Advise Against Tenofovir for HIV Patients With Kidney Disease

    HIV-positive patients who have reduced kidney function should take antiretroviral therapy, but should avoid regimens that contain tenofovir (Viread), according to updated treatment guidelines from the HIV Medicine Association (HIVMA).

    22 September 2014 | The Body Pro
  • Switch From Efavirenz to Rilpivirine Quells CNS Toxicity, Improves Sleep

    Switching from Atripla (efavirenz plus tenofovir/emtricitabine [TDF/FTC]) to Complera (Eviplera, rilpivirine plus TDF/FTC) significantly relieved central nervous system (CNS) toxicity and improved sleep in people with those problems while taking Atripla [1]. All but 1 of 40 study participants who switched in this London/Brighton study maintained virologic control through 24 weeks.

    16 September 2014 | NATAP
  • New Tenofovir Alafenamide Combo Pill Has Less Effect on Kidneys and Bones

    An experimental single-tablet regimen containing a new version of tenofovir (tenofovir alafenamide or TAF) and the HIV protease inhibitor darunavir (Prezista) worked as well as a similar regimen containing the older tenofovir disoproxil fumarate (TDF) formulation,but it had less detrimental effects on kidney function and bone density, as study presented at the recent ICAAC conference heard.

    09 September 2014 | HIVandhepatitis.com
  • Drug that reduces abdominal fat in HIV patients also may reduce fat in liver

    The only drug to receive Food and Drug Administration approval for reduction of the abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection may also reduce the incidence of fatty liver disease in such patients. Massachusetts General Hospital investigators report that six months of daily injections of tesamorelin significantly reduced fat in the liver without affecting glucose metabolism.

    19 July 2014 | Eurekalert Medicine & Health
  • Common HIV Drug May Boost Suicide Risk

    A medication commonly used to treat HIV appears to double the risk that patients will develop suicidal thoughts or take their lives, new research contends. The finding concerns the anti-HIV drug efavirenz, which is marketed as Sustiva.

    02 July 2014 | Web MD
  • Lowering toxicity of new HIV drugs predicted to improve life expectancy

    While bringing new drugs to market is important for increasing life expectancy in younger people with HIV, lowering the toxicity of those drugs may have an even greater health impact on all HIV patients, a University of Pittsburgh Graduate School of Public Health analysis reveals.

    26 June 2014 | EurekAlert
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.